The IMARC Group's latest research report, titled “Oral Proteins and Peptides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” offers a comprehensive analysis of the oral proteins and peptides market insights. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032.

Oral Proteins and Peptides Market Trends:

The global oral proteins and peptides market is experiencing substantial growth, driven by the increasing prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders. The rising demand for non-invasive and patient-friendly drug delivery systems is significantly boosting the development and adoption of oral proteins and peptides. Additionally, advancements in drug formulation technologies are enhancing the stability and bioavailability of these therapeutics, further driving market growth. The growing investment in biopharmaceutical research and the expanding pipeline of oral protein and peptide therapeutics are contributing to market expansion. Furthermore, the emphasis on personalized medicine and targeted therapies is fostering the development of specialized oral protein and peptide drugs. Along with this, the support from regulatory bodies for innovative drug delivery systems and the increasing collaboration between pharmaceutical companies and research institutions are driving the market forward.

Get Sample Copy of Report at – https://www.imarcgroup.com/oral-proteins-peptides-market/requestsample

Oral Proteins and Peptides Market Scope & Growth Analysis:

The scope of the market is extensive, encompassing various therapeutic areas, including metabolic disorders, oncology, gastrointestinal diseases, and hormonal disorders. The market is segmented by drug type, such as insulin, GLP-1 agonists, and PTH analogs, with significant growth expected across all segments. The increasing adoption of oral protein and peptide therapeutics in both developed and emerging markets is witnessing notable growth, driven by improved patient compliance and convenience. The North American region is emerging as a key market due to the high prevalence of chronic diseases, advanced healthcare infrastructure, and significant R&D investments. In addition, the ongoing advancements in drug delivery technologies, aimed at overcoming the challenges of protein and peptide degradation in the gastrointestinal tract, are expected to drive innovation and market expansion. Moreover, the rise of biosimilars and the increasing focus on cost-effective therapies are creating a positive market outlook.

Competitive Landscape with Key Players:

• Amryt Pharma Plc
• AstraZeneca PLC
• Biocon Limited
• Novo Nordisk A/S
• Oramed Ltd
• Proxima Concepts Limited

Key Market Segmentation:

Drug Type Insights:

• Linaclotide
• Plecanatide
• Calcitonin
• Insulin
• Octreotide

Application Insights:

• Gastric and Digestive Disorders
• Bone Diseases
• Diabetes
• Hormonal Disorders

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance 
• Market Outlook
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145